Abstract
Background
MicroRNAs (miRNAs) have been reported to play important roles in regulating natural killer (NK) cell cytotoxicity to cancer cells.
Objective
This study aimed to investigate the effects and potential mechanism of miR-30c in regulating NK cell cytotoxicity to lung cancer cells.
Methods
Primary NK cells were derived from the peripheral blood of lung cancer and normal participants. Exosomes were isolated and validated via transmission electron microscopy and nanoparticle tracking analysis. The levels of miR-30c, polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) and proteins in PI3K/AKT pathway were determined using quantitative real-time polymerase chain reaction or western blot. Tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ) levels and the cytotoxicity of effector NK cells to target lung cancer cells were measured via enzyme linked immunosorbent assay, cell apoptosis or xenograft experiments. The relationship between miR-30c and GALNT7 was analyzed by luciferase activity, RNA pull-down and RNA immunoprecipitation assays. And a xenograft mice model was established to verify the effect of miR-30c in regulating NK cell cytotoxicity to lung cancer cells in vivo.
Results
NK cell-derived exosomes carrying miR-30c, and miR-30c level was significantly downregulated in primary NK cells of lung cancer patients. MiR-30c overexpression promoted TNF-α and IFN-γ secretion and enhanced the cytotoxicity of interleukin 2 (IL-2)-treated NK cells to lung cancer cells, while knockdown of miR-30c played an opposite effect in regulating the cytotoxicity of NK cells to lung cancer cells. GALNT7 was a target of miR-30c and was negatively regulated by miR-30c. Besides, miR-30c targeted GALNT7 to exert its function in regulating NK cell cytotoxicity. Furthermore, GALNT7 prompted the activation of PI3K/AKT pathway in NK cells. Additionally, miR-30c overexpression enhanced NK cell cytotoxicity to lung cancer cells and inhibited tumor growth in vivo.
Conclusion
miR-30c enhanced NK cell cytotoxicity to lung cancer cells via decreasing GALNT7 and inactivating the PI3K/AKT pathway, suggesting that regulating miR-30c expression maybe a promising approach for enhancing NK cell-based antitumor therapies.
Similar content being viewed by others
Abbreviations
- miRNAs:
-
MicroRNAs
- NK:
-
Natural killer
- GALNT7:
-
N-acetylgalactosaminyltransferase 7
- TNF-α:
-
Tumor necrosis factor-α
- IFN-γ:
-
Interferon-γ
- IL-2:
-
Interleukin 2
References
Abel AM, Yang C, Thakar MS, Malarkannan S (2018) Natural killer cells: development, maturation, and clinical utilization. Front Immunol 9:1869
Aktaş ON, Öztürk AB, Erman B, Erus S, Tanju S, Dilege Ş (2018) Role of natural killer cells in lung cancer. J Cancer Res Clin Oncol 144:997–1003
Alfarra H, Weir J, Grieve S, Reiman T (2020) Targeting NK cell inhibitory receptors for precision multiple myeloma immunotherapy. Front Immunol 11:575609
Ali AK, Nandagopal N, Lee SH (2015) IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells. Front Immunol 6:355
Beavis PA, Slaney CY, Kershaw MH, Gyorki D, Neeson PJ, Darcy PK (2016) Reprogramming the tumor microenvironment to enhance adoptive cellular therapy. Semin Immunol 28:64–72
Cao Q, Wang N, Ren L, Tian J, Yang S, Cheng H (2020) miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway. Cancer Cell Int 20:117
Cong J, Wang X, Zheng X, Wang D, Fu B, Sun R, Tian Z, Wei H (2018) Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression. Cell Metab 28:243-255.e245
Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA (2019) Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer 58:244–253
Eichmüller SB, Osen W, Mandelboim O, Seliger B (2017) Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst 109:1–14
Gong J, Liu R, Zhuang R, Zhang Y, Fang L, Xu Z, Jin L, Wang T, Song C, Yang K et al (2012) miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1. Cancer Sci 103:645–652
Hammer Q, Rückert T, Romagnani C (2018) Natural killer cell specificity for viral infections. Nat Immunol 19:800–808
Hua S, Li H, Liu Y, Zhang J, Cheng Y, Dai C (2018) High expression of GALNT7 promotes invasion and proliferation of glioma cells. Oncol Lett 16:6307–6314
Iams WT, Porter J, Horn L (2020) Immunotherapeutic approaches for small-cell lung cancer. Nat Rev Clin Oncol 17:300–312
Ingenito F, Roscigno G, Affinito A, Nuzzo S, Scognamiglio I, Quintavalle C, Condorelli G (2019) The role of exo-miRNAs in cancer: a focus on therapeutic and diagnostic applications. Int J Mol Sci 20:1–8
Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA (2019) MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Asp Med 70:3–20
Javadinia SA, Shahidsales S, Fanipakdel A, Mostafapour A, Joudi-Mashhad M, Ferns GA, Avan A (2018) The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: a novel marker for prognosis, and a possible target for immunotherapy. Curr Pharm Des 24:4646–4651
Jin F, Wu Z, Hu X, Zhang J, Gao Z, Han X, Qin J, Li C, Wang Y (2019) The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility. Cancer Biol Med 16:38–54
Khong A, Nelson DJ, Nowak AK, Lake RA, Robinson BW (2012) The use of agonistic anti-CD40 therapy in treatments for cancer. Int Rev Immunol 31:246–266
Lai YH, Chen J, Wang XP, Wu YQ, Peng HT, Lin XH, Wang WJ (2017) Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer. J Exp Clin Cancer Res 36:92
Leong JW, Wagner JA, Ireland AR, Fehniger TA (2017) Transcriptional and post-transcriptional regulation of NK cell development and function. Clin Immunol 177:60–69
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, Jia L (2018) Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol 11:89
Liu Y, Cheng Y, Xu Y, Wang Z, Du X, Li C, Peng J, Gao L, Liang X, Ma C (2017) Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers. Oncogene 36:6143–6153
Liu P, Chen L, Zhang H (2018) Natural killer cells in liver disease and hepatocellular carcinoma and the NK cell-based immunotherapy. J Immunol Res 2018:1206737
Ma Y, Gong J, Liu Y, Guo W, Jin B, Wang X, Chen L (2016) MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D. Life Sci 151:174–181
Ma T, Zhao Y, Lu Q, Lu Y, Liu Z, Xue T, Shao Y (2018) MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma. Biomed Pharmacother 98:680–686
McDonnell AM, Currie AJ, Brown M, Kania K, Wylie B, Cleaver A, Lake R, Robinson BW (2012) Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation. Oncoimmunology 1:840–846
Muenst S, Läubli H, Soysal SD, Zippelius A, Tzankov A, Hoeller S (2016) The immune system and cancer evasion strategies: therapeutic concepts. J Intern Med 279:541–562
Myers JA, Miller JS (2021) Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol 18:85–100
Nie GH, Luo L, Duan HF, Li XQ, Yin MJ, Li Z, Zhang W (2016) GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma. Tumour Biol 37:4559–4567
O’Donnell JS, Massi D, Teng MWL, Mandala M (2018) PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol 48:91–103
Pan C, Xiang L, Pan Z, Wang X, Li J, Zhuge L, Fang P, Xie Q, Hu X (2018) MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer. Cancer Cell Int 18:52
Shi P, Yin T, Zhou F, Cui P, Gou S, Wang C (2014) Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. BMC Cancer 14:370
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
Song X, Jiao X, Yan H, Yu L, Jiang L, Zhang M, Chen L, Ju M, Wang L, Wei Q et al (2021) Overexpression of PTPRN promotes metastasis of lung adenocarcinoma and suppresses NK cell cytotoxicity. Front Cell Dev Biol 9:622018
Steven A, Fisher SA, Robinson BW (2016) Immunotherapy for lung cancer. Respirology 21:821–833
Wang JB, Chen XL, Han ZB, Wang HW, Wang ZH, Li NN, Lin ZG (2020) Long non-coding RNA TP73-AS1 contributes to glioma tumorigenesis by sponging the miR-103a/GALNT7 pathway. Brain Res 1741:146886
Wang Y, Wang C, Fu Z, Zhang S, Chen J (2021) miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway. Cancer Cell Int 21:618
Wu H, Chen J, Li D, Liu X, Li L, Wang K (2017) MicroRNA-30e functions as a tumor suppressor in cervical carcinoma cells through targeting GALNT7. Transl Oncol 10:876–885
Wu SJ, Chen J, Wu B, Wang YJ, Guo KY (2018) MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma. J Exp Clin Cancer Res 37:18
Xia C, He Z, Cai Y, Liang S (2020) Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells. Eur J Pharmacol 875:173057
Xu SJ, Hu HT, Li HL, Chang S (2019) The role of miRNAs in immune cell development, immune cell activation, and tumor immunity: with a focus on macrophages and natural killer cells. Cells 8:1–20
Yang Q, Li J, Hu Y, Tang X, Yu L, Dong L, Chen D (2019a) MiR-218-5p suppresses the killing effect of natural killer cell to lung adenocarcinoma by targeting SHMT1. Yonsei Med J 60:500–508
Yang S, Zhang Z, Wang Q (2019b) Emerging therapies for small cell lung cancer. J Hematol Oncol 12:47
Zhang LL, Zhang LF, Shi YB (2018) miR-24 inhibited the killing effect of natural killer cells to colorectal cancer cells by downregulating Paxillin. Biomed Pharmacother 101:257–263
Zhang D, Lee H, Wang X, Groot M, Sharma L, Dela Cruz CS, Jin Y (2019) A potential role of microvesicle-containing miR-223/142 in lung inflammation. Thorax 74:865–874
Zhao GS, Liu S, Yang L, Li C, Wang RY, Zhou J, Zhang YW (2020) Evaluation of radioactive (125)I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety. BMC Cancer 20:718
Zhong K, Chen K, Han L, Li B (2014) MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 14:703
Zhou X, Liu S, Liu J, Zhang Z, Mao X, Zhou H (2020) MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3. Biochem Biophys Res Commun 523:481–486
Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee SW, Lee J, Ahn BC (2017) Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 7:2732–2745
Acknowledgements
Not applicable.
Author information
Authors and Affiliations
Contributions
Fei Gao,Jianjun Han design and research the experiment procedure, write the revision and article, Li Jia, Jun He, Yun Wang, Mi Chen, Xiaojun Liu and Xia He conduct experiments and collect data, and prepare for the preliminary survey, corresponding to Jianjun Han.
Corresponding author
Ethics declarations
Conflict of interest
Author Fei Gao, Author Jianjun Han,Author Li Jia, Author Jun He, Author Yun Wang, Author Mi Chen, Author Xiaojun Liu and Author Xia He declare that they have no conflicts of interests.
Declaration of Helsinki
All clinical experiments that include human blood samples or animal experiments were approved by the Ethics Committee of The Third Hospital of Mianyang. All procedures and protocols were performed according to the Declaration of Helsinki. The written consent of participants included in the study was obtained.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gao, F., Han, J., Jia, L. et al. MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7. Genes Genom 45, 247–260 (2023). https://doi.org/10.1007/s13258-022-01306-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-022-01306-0